Biomarker-guided care for mild traumatic brain injury using GFAP and UCH-L1
Official title: BLOOD BIOMARKERS TO IMPROVE MANAGEMENT OF MILD TRAUMATIC BRAIN INJURY IMPLIMENTACIÓN STUDY
Run by Hospital Universitario 12 de Octubre · NCT07311486 · Data updated 2026-11-12
This project will try a blood test that measures GFAP and UCH-L1 to see if adults with recent mild traumatic brain injury can safely avoid a head CT.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Hospital Universitario 12 de Octubre Academic / other |
| Locations | 1 site (Madrid, Madrid) |
| Status | Recruiting |
| Started | July 15, 2025 |
| Main results expected | May 1, 2026 |
| Study ends | May 1, 2026 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT07311486 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18+) who present to the ER within 12 hours of a plausible head injury with GCS 13–15 and clinical signs or symptoms of mild TBI, and who can provide a blood sample before imaging.
✕Probably not a fit
Patients with moderate or severe TBI (GCS ≤12), children, those with unknown or >12-hour time since injury, or those needing immediate imaging are unlikely to benefit from this pathway.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This ambispective cohort study at Hospital Universitario 12 de Octubre implements a clinical pathway using the VIDAS TBI blood assay (GFAP and UCH-L1) within 12 hours of injury to guide CT decisions for mild TBI. Patients managed under the new biomarker-based pathway will be compared to a historical six-month cohort treated before the pathway was introduced. Key outcomes are diagnostic performance for ruling out CT need, safety (missed intracranial injuries or neurological deterioration), and operational impact such as CT use and emergency department length of stay. Blood samples are obtained before imaging and predefined biomarker thresholds are applied as part of routine ER care.
Why it matters
Potential benefit: If successful, it could safely reduce unnecessary head CT scans and shorten emergency department stays for people with mild TBI.
How similar studies have gone: Previous work using GFAP and UCH-L1 has shown promise and supported regulatory clearance of similar biomarker tests, though real-world implementation in ER pathways remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * -All adult patients suffering mild TBI:( Defined by at least criterion a) and d) and one or more of the other criteria) 1. The presence of a plausible traumatic mechanism observed/or related by the patient´s recount of the injury event. 2. Presence of one or more clinical signs attributable to brain injury: Loss of consciousness immediately following injury, alteration of mental status immediately following the injury, posttraumatic amnesia or any neurological abnormality. 3. At least two acute symptoms related to the injury: feeling confused or disoriented, headache, nausea, vomiting, dizziness, vision problems, memory problems, emotional lability or irritability. 4. a GCS between 15 and 13, at least 30 minutes after injury. * Blood sample obtained ≤12 h after injury and ideally before any imaging prescription. Exclusion Criteria: * · GCS 3-12 on admission * Age Below 18 years * Time of injury unknown * Time to injury exceeding 12 hours * Primary admission for non-traumatic neurological disorder (e.g., stroke, spontaneous, intracranial hematoma) * Penetrating head trauma * Patient with mechanical ventilation from the trauma scene or prehospital management * Venipuncture not feasible
Where it's running
-
Hospital Universitario 12 de Octubre
Madrid, Madrid, Spain Recruiting
Study contacts
- Principal investigator: Alfonso Lagares, MD, PhD — Hospital Universitario 12 de Octubre
- Study coordinator: Alfonso Lagares, MD, PhD
- Email: alfonlag@ucm.es
- Phone: +34913908000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if Man Therapy helps reduce problematic anger in male service members with or without a mild TBI
This trial tests whether the Man Therapy online program can lower problematic anger in male military members who screen positive for anger, compared to a waitlist.
-
Motor Activation Therapy after concussion: a targeted rehabilitation approach
This study tests a motor-activation focused physical therapy for people with persistent balance problems after a concussion to see if it improves their responses to imbalance.
-
Symptom-Targeted Rehabilitation for Concussion (STAR-C)
This project will test whether in-person and telehealth STAR‑C help adults with past concussions reduce everyday cognitive complaints.
-
Combining Acceptance and Commitment Therapy with Vestibular Rehabilitation for mTBI
This study is testing if combining a therapy that helps with acceptance and commitment with standard balance exercises can better help military service members with mild traumatic brain injury and related symptoms feel better.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury
A group therapy program based on EAET is tested to see if it helps adults 18-65 with acquired brain injury improve emotional well-being and daily functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.